0.68 (2.72%)Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Merck & Co. Inc. Shs Sponsored Canadian Depository Receipt Hedged Reg S
Telephone
Address
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 23.61 - 28.11
Trade Value (12mth)
US$7,488.00
1 week
2.72%
1 month
1.7%
YTD
6.99%
1 year
0%
All time high
28.11
EPS 3 yr Growth
36.60%
EBITDA Margin
45.20%
Operating Cashflow
$23,016m
Free Cash Flow Return
18.10%
ROIC
20.00%
Interest Coverage
21.60
Quick Ratio
1.30
Shares Outstanding (Fully Diluted)
2,472m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
16-Mar-26
Next Dividend Pay Date
14-Apr-26
Reporting Currency
CAD
Short Sell (% of issue)
0.00
Historical data
Forecast data
| CAD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | 0.19 | 9.26 | 10.19 | | | | ||
EPS (Fully Diluted) | $ | | | | | 0.19 | 9.23 | 10.17 | | | | ||
Growth | % | | | | | -97.4 | 4,668.9 | 10.1 | | | | ||
PE | X | | | | | N/A | N/A | 2.3 | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | 2.6 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
